Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer

Published:2005-01 Issue:1 Volume:41 Page:81-92
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Martoni A.,Marino A.,Sperandi F.,Giaquinta S.,Di Fabio F.,Melotti B.,Guaraldi M.,Palomba G.,Preti P.,Petralia A.,Artioli F.,Picece V.,Farris A.,Mantovani L.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why?;Bunn;J Clin Oncol,2002

2. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients;Le Chevalier;J Clin Oncol,1994

3. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group trial;Wozniak;J Clin Oncol,1998

4. Multicenter randomized clinical trial on high-dose epirubicin plus cis-platin versus vinorelbine plus cis-platinum in advanced non-small cell lung cancer;Martoni;Lung Cancer,1998

5. Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small-cell lung cancer: preliminary results;Steward;Semin Oncol,1997

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The best regimens for chemo-naïve incurable non-squamous non- small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1–49%: a network meta-analysis;Translational Lung Cancer Research;2021-08

Changes and Influential Factors of Chemotherapy Usage for Non-Small Cell Lung Cancer Patients in China: A Multicenter 10-Year (2005–2014) Retrospective Study

;Cancer Management and Research;2020-07

3. A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer;Journal of Thoracic Disease;2019-08

4. Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer;European Respiratory Journal;2018-11-28

5. Intracellular pathway of halloysite nanotubes: potential application for antitumor drug delivery;Journal of Materials Science;2018-08-10